Connect with us

Hi, what are you looking for?

Economy

Alabama Innovation Fund, Auburn support development of saliva COVID testing device

Taking a sample of saliva from the lips of a woman close up

The Alabama Department of Commerce and the City of Auburn’s Industrial Development Board have teamed to award $250,000 in funding to accelerate the development of OraSecure LLC’s breakthrough patent-pending saliva collection device intended to help in the ongoing battle against the novel coronavirus.

Support from the Alabama Innovation Fund and the City of Auburn will help OraSecure finalize the initial manufacturing run needed to begin mass producing its devices and complete validation with the FDA. Production of the devices will take place in Auburn.

“The Alabama Innovation Fund is a key component in our efforts to spark the creation of high-impact ’Made in Alabama’ products by stimulating breakthrough research,” said Greg Canfield, secretary of the Alabama Department of Commerce. “With this support, we are helping OraSecure speed the development of a specimen collection device that can make a difference in the pandemic response while simultaneously raising the state’s profile in the bioscience industry.”

For more information, see the attachment or click this link: https://www.madeinalabama.com/2020/07/orasecure_saliva_collection_device/

 

Written By

The Alabama Political Reporter is a daily political news site devoted to Alabama politics. We provide accurate, reliable coverage of policy, elections and government.

DIG DEEPER

Health

The Medical Association of the State of Alabama will host State Health Officer Dr. Scott Harris and UAB's Dr. David Kimberlin.

Education

It's up to local school systems whether to follow the guidance, however. Gov. Kay Ivey said she won't mandate masks.

Health

The state's seven-day average of new daily cases Wednesday was an 815 percent increase from the average on July 1. 

Health

The events will offer free backpacks, free tickets to the Alabama National Fair, and more after second dose.